SCM
CDMO

Soleus Capital Management’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Soleus Capital Management’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-135,000
Closed -$2.91M – 88
2021
Q3 		$2.91M Buy
+135,000
New +$3.26M 0.45% 54

Other funds holding CDMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
ICM
ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Soleus Capital Management's CDMO Position: Q4 2021 in Review

Soleus Capital Management sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q4 2021, closing a stake of 135,000 shares — an estimated $2.91M sold.

Soleus Capital Management first reported a position in CDMO in Q3 2021 and held it in 1 quarter. The position peaked at $2.91M in Q3 2021. 190 funds tracked by Wall St. Rank hold CDMO as of Q4 2021.

  • Soleus Capital Management reported no remaining Avid Bioservices, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Soleus Capital Management sold 135,000 Avid Bioservices, Inc. Common Stock shares in Q4 2021, an estimated $2.91M.
  • Soleus Capital Management first reported a position in Avid Bioservices, Inc. Common Stock in Q3 2021 and held it in 1 quarter.
  • Soleus Capital Management's Avid Bioservices, Inc. Common Stock position peaked at $2.91M in Q3 2021.
  • 190 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q4 2021.

Based on Soleus Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.